BioNTech Cancer Vaccine Trial Faces Setback
A cancer vaccine made by BioNTech and Genentech did not help patients, raising questions about this new treatment.
Doctors hoped a new cancer vaccine from BioNTech and Genentech would help patients. This vaccine aimed to train the body to fight cancer. The trial was for people with melanoma, a serious skin cancer. They tested the vaccine alongside a strong cancer drug called Keytruda.
But the results disappointed everyone. The trial showed that more people died who received the vaccine than those who did not. This was a surprise, as another similar vaccine from Merck and Moderna showed good results. That vaccine also used Keytruda.
Because of these sad findings, the companies stopped the trial early. This makes doctors wonder if this type of vaccine needs to be given with other treatments to work well. Researchers keep working hard to find new ways to fight cancer.
Source: FierceBiotech
More from Biotech
